Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.100 GeneticVariation disease BEFREE B-Raf(V600E) cells in which either B-Raf(V600E) or TSP-1 were knocked down were implanted orthotopically into the thyroids of immunocompromised mice, resulting in significant reduction in tumor size and fewer pulmonary metastases from the primary carcinoma as compared with the control cells. 20498063 2010
Entrez Id: 2697
Gene Symbol: GJA1
GJA1
0.040 Biomarker disease BEFREE Cx43 suppresses mammary tumor metastasis to the lung in a Cx43 mutant mouse model of human disease. 21151177 2011
Entrez Id: 11279
Gene Symbol: KLF8
KLF8
0.020 Biomarker disease BEFREE KLF8 knockdown inhibited the lung metastasis of MDA-MB-231 cells in nude mice. 21151179 2011
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.100 GeneticVariation disease BEFREE KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancer. 21239505 2011
Entrez Id: 55612
Gene Symbol: FERMT1
FERMT1
0.020 AlteredExpression disease BEFREE Kindlin-1 expression was associated with metastasis-free survival in both breast and lung adenocarcinoma (breast cancer: hazard ratio of lung metastasis = 2.55, 95% confidence intervals [CI] = 1.39 to 4.69, P = .001; lung cancer: hazard ratio of metastasis = 1.96, 95% CI = 1.25 to 3.07, P = .001). 21832234 2011
Entrez Id: 84634
Gene Symbol: KISS1R
KISS1R
0.020 Biomarker disease BEFREE Kiss1r heterozygosity in MMTV-PyMT mice was sufficient to attenuate breast cancer initiation, growth, latency, multiplicity, and lung metastasis. 21852382 2011
Entrez Id: 8877
Gene Symbol: SPHK1
SPHK1
0.030 AlteredExpression disease BEFREE SPHK1 overexpression significantly increased the invasiveness of EC9706 cells in vitro and also increased EC9706 cell growth and spontaneous metastasis in vivo, promoting significant increases in tumor growth, tumor burden and spontaneous lung metastasis in nude mice. 21936950 2011
Entrez Id: 196
Gene Symbol: AHR
AHR
0.010 AlteredExpression disease BEFREE Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells. 22034498 2012
Entrez Id: 1268
Gene Symbol: CNR1
CNR1
0.010 Biomarker disease BEFREE Cnr1 loss by either route also dramatically reduced lung metastasis formation. 22037868 2011
Entrez Id: 1462
Gene Symbol: VCAN
VCAN
0.020 Biomarker disease BEFREE Versican knockdown in the bone marrow significantly impaired lung metastases in vivo, without impacting their recruitment to the lungs or altering the immune microenvironment. 22282653 2012
Entrez Id: 857
Gene Symbol: CAV1
CAV1
0.100 Biomarker disease BEFREE Caveolin-1 silencing arrests the proliferation of metastatic lung cancer cells through the inhibition of STAT3 signaling. 22406084 2012
Entrez Id: 2296
Gene Symbol: FOXC1
FOXC1
0.070 AlteredExpression disease BEFREE FoxC1 overexpression induced changes characteristic of EMT and an increase in HCC cell invasion and lung metastasis. 22911555 2013
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.090 AlteredExpression disease BEFREE Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), delivered as a membrane-bound molecule expressed on the surface of adenovirus-transduced CD34(+) cells (CD34-TRAIL(+)), was analyzed for its apoptotic activity in vitro on 12 breast cancer cell lines representing estrogen receptor-positive, HER2(+) and triple-negative (TN) subtypes and for its effect on tumor growth, vascularization, necrosis, and lung metastasis incidence in NOD/SCID mice xenografted with the TN breast cancer line MDA-MB-231. 23053664 2012
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.100 Biomarker disease BEFREE VEGF-induced lung metastasis in MV165 is inhibited by MLN0128 and rapamycin. 23085766 2012
Entrez Id: 23081
Gene Symbol: KDM4C
KDM4C
0.020 AlteredExpression disease BEFREE JMJD2C decreases trimethylation of histone H3 at lysine 9, and enhances HIF-1 binding to hypoxia response elements, thereby activating transcription of BNIP3, LDHA, PDK1, and SLC2A1, which encode proteins that are required for metabolic reprogramming, as well as LOXL2 and L1CAM, which encode proteins that are required for lung metastasis. 23129632 2012
Entrez Id: 3579
Gene Symbol: CXCR2
CXCR2
0.020 AlteredExpression disease BEFREE CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma. 23204236 2013
Entrez Id: 5008
Gene Symbol: OSM
OSM
0.030 Biomarker disease BEFREE OSM stimulation promotes spontaneous lung metastasis of MCF-7 xenografts in nude mice. 23318420 2013
Entrez Id: 3439
Gene Symbol: IFNA1
IFNA1
0.010 Biomarker disease BEFREE IFN-α inhibited lung metastasis by directly modulating the lung microenvironment. 23527047 2013
Entrez Id: 3447
Gene Symbol: IFNA13
IFNA13
0.010 Biomarker disease BEFREE IFN-α inhibited lung metastasis by directly modulating the lung microenvironment. 23527047 2013
Entrez Id: 4076
Gene Symbol: CAPRIN1
CAPRIN1
0.020 Biomarker disease BEFREE Caprin-1, a novel Cyr61-interacting protein, promotes osteosarcoma tumor growth and lung metastasis in mice. 23528710 2013
Entrez Id: 8038
Gene Symbol: ADAM12
ADAM12
0.010 Biomarker disease BEFREE ADAM12-cleaved ephrin-A1 contributes to lung metastasis. 23686306 2014
Entrez Id: 57007
Gene Symbol: ACKR3
ACKR3
0.050 AlteredExpression disease BEFREE CXCR7 was expressed on human primary bone tumours and on lung metastases. 24002596 2013
Entrez Id: 9219
Gene Symbol: MTA2
MTA2
0.010 Biomarker disease BEFREE MTA2 knockdown also attenuated xenografts growth and lung metastasis in nude mice model. 24010737 2013
Entrez Id: 29110
Gene Symbol: TBK1
TBK1
0.020 AlteredExpression disease BEFREE TBK1 silencing decreased expression of epithelial markers and increased expression of mesenchymal markers in ERα-positive breast cancer cells, enhancing tumor growth and lung metastasis in vivo in a manner associated with downregulation of ERα expression. 24062311 2013
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.100 AlteredExpression disease BEFREE EGFR expression was evident in 49 % of the PMs, whereas Mts in KRAS and BRAF were detected in 48 and 0 %, respectively. 24281417 2014